Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
- 1 July 2011
- Vol. 29 (32) , 5221-5231
- https://doi.org/10.1016/j.vaccine.2011.05.027
Abstract
No abstract availableKeywords
Funding Information
- Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center (1 U19 AI062150-01)
This publication has 63 references indexed in Scilit:
- An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like ParticlesClinical and Vaccine Immunology, 2010
- Serological Correlate of Protection against Norovirus‐Induced GastroenteritisThe Journal of Infectious Diseases, 2010
- Oral Vaccine Formulations Stimulate Mucosal and Systemic Antibody Responses against Staphylococcal Enterotoxin B in a Piglet ModelClinical and Vaccine Immunology, 2010
- Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccinationMucosal Immunology, 2010
- Assessing the immunopotency of Toll‐like receptor agonists in an in vitro tissue‐engineered immunological modelImmunology, 2010
- Norwalk virus-like particles as vaccinesExpert Review of Vaccines, 2010
- Evaluation of Mucoadhesive PLGA Microparticles for Nasal ImmunizationThe AAPS Journal, 2010
- Intradermal immunization improves protective efficacy of a novel TB vaccine candidateVaccine, 2009
- Systematic Literature Review of Role of Noroviruses in Sporadic GastroenteritisEmerging Infectious Diseases, 2008
- An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particlesVaccine, 2008